Boehringer Ingelheim Pharma GmbH & Co. KG

The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritis (2021) Mayer AL, Scheitacker I, Ebert N, Klein T, Amann KU, Daniel C Journal article Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry. (2021) Ntaios G, Huisman M, Diener HC, Halperin JL, Teutsch C, Marler S, Gurusamy VK, et al. Journal article Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. (2021) Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airo P, Ananieva LP, Czirjak L, et al. Journal article The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease. (2021) Wollin L, Trinh MT, Zhang Y, Distler J Journal article The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease (2021) Wollin L, Trinh MT, Zhang Y, Distler J Journal article Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial (2021) Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Journal article Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib (2020) Matteson E, Distler O, Distler J, Kuwana M, Pope J, Seibold J, James A, et al. Conference contribution Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function (2020) Wuyts WA, Azuma A, Distler J, Sondergaard K, Proudman S, Cottin V, Erhardt E, et al. Conference contribution Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease (2020) Vergnano M, Mockenhaupt M, Benzian-Olsson N, Paulmann M, Grys K, Mahil SK, Chaloner C, et al. Journal article Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: Data from the RE-LY trial (2020) Böhm M, Brueckmann M, Eikelboom JW, Ezekowitz M, Fräßdorf M, Hijazi Z, Hohnloser SH, et al. Journal article